tiprankstipranks
Advertisement
Advertisement
Schrodinger reports Q2 EPS 8c, consensus (39c)
PremiumThe FlySchrodinger reports Q2 EPS 8c, consensus (39c)
1M ago
Schrodinger raises FY26 drug discovery revenue view $65M-$75M from $55M-$65M
Premium
The Fly
Schrodinger raises FY26 drug discovery revenue view $65M-$75M from $55M-$65M
1M ago
Schrodinger announces collaboration, software agreement with Bristol Myers
Premium
The Fly
Schrodinger announces collaboration, software agreement with Bristol Myers
1M ago
Schrödinger Shareholders Expand Equity Plan, Elect Directors
PremiumCompany AnnouncementsSchrödinger Shareholders Expand Equity Plan, Elect Directors
3M ago
Schrodinger reports inducement grants under Nasdaq listing rule
Premium
The Fly
Schrodinger reports inducement grants under Nasdaq listing rule
3M ago
Schrödinger Finalizes Transition Terms for Former Commercial Chief
Premium
Company Announcements
Schrödinger Finalizes Transition Terms for Former Commercial Chief
3M ago
Private Markets: $2.1B for Isomorphic Labs, massive raise looming for Anthropic
PremiumThe FlyPrivate Markets: $2.1B for Isomorphic Labs, massive raise looming for Anthropic
4M ago
Schrodinger price target lowered to $17 from $19 at Morgan Stanley
Premium
The Fly
Schrodinger price target lowered to $17 from $19 at Morgan Stanley
4M ago
Evan Seigerman Reiterates Buy on Schrödinger as Software Expansion and Partnered Successes Strengthen Long-Term Growth Outlook
Premium
Ratings
Evan Seigerman Reiterates Buy on Schrödinger as Software Expansion and Partnered Successes Strengthen Long-Term Growth Outlook
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100